Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics

Modern Pathology

Volumn 23, Issue 9, 2010, Pages 1279-1288

  Yoshida, Akihiko ^a,b   Ushiku, Tetsuo ^b   Motoi, Toru ^c   Shibata, Tatsuhiro ^d   Beppu, Yasuo ^a   Fukayama, Masashi ^b   Tsuda, Hitoshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; PROTEIN MDM2;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXOSTOSIS; FEMALE; FIBROMA; FIBROUS DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; JUXTACORTICAL OSTEOSARCOMA; LOW GRADE CENTRAL OSTEOSARCOMA; MALE; OSSIFYING MYOSITIS; OSTEOCHONDROMA; OSTEOSARCOMA; PERIOSTITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

EID: 77956275003     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.124     Document Type: Article

References (35)

1. Schwab JH, Antonescu CR, Athanasian EA, et al. A comparison of intramedullary and juxtacortical low-grade osteogenic sarcoma. Clin Orthop Relat Res 2008;466:1318-1322.
2. Dorfman HD, Czerniak B. Bone Tumors. Mosby: St Louis, 1998.
3. Unni KK, Inwards CY, Bridge JA, et al. Tumors of the Bones and Joints. ARP Press: Silver Spring, 2005.
4. Fletcher CDM, Unni KK, Mertens F, eds Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press: Lyon, 2002.
5. Mirra JM, Picci P, Gold RH. Bone Tumors: Clinical, Radiologic, and Pathologic Correlations. Lea & Febiger: Philadelphia, 1989.
6. Okada K, Frassica FJ, Sim FH, et al. Parosteal osteosarcoma. A clinicopathological study. J Bone Joint Surg Am 1994;76:366-378.
7. Kurt AM, Unni KK, McLeod RA, et al. Low-grade intraosseous osteosarcoma. Cancer 1990;65:1418-1428.
8. Sheth DS, Yasko AW, Raymond AK, et al. Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome. Cancer 1996;78:2136-2145.
9. Orndal C, Mandahl N, Rydholm A, et al. Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy. Cancer Genet Cytogenet 1992;60:170-175.
10. Sinovic JF, Bridge JA, Neff JR. Ring chromosome in parosteal osteosarcoma. Clinical and diagnostic significance. Cancer Genet Cytogenet 1992;62:50-52.
11. Gisselsson D, Palsson E, Hoglund M, et al. Differentially amplified chromosome 12 sequences in low-and high-grade osteosarcoma. Genes Chromosomes Cancer 2002;33:133-140.
12. Szymanska J, Mandahl N, Mertens F, et al. Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study. Genes Chromosomes Cancer 1996;16:31-34.
13. Tarkkanen M, Karhu R, Kallioniemi A, et al. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 1995; 55:1334-1338.
14. Tarkkanen M, Bohling T, Gamberi G, et al. Comparative genomic hybridization of low-grade central osteosarcoma. Mod Pathol 1998;11:421-426.
15. Gamberi G, Ragazzini P, Benassi MS, et al. Analysis of 12q13-15 genes in parosteal osteosarcoma. Clin Orthop Relat Res 2000;377:195-204.
16. Wunder JS, Eppert K, Burrow SR, et al. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene 1999;18:783-788.
17. Noble-Topham SE, Burrow SR, Eppert K, et al. SAS is amplified predominantly in surface osteosarcoma. J Orthop Res 1996;14:700-705.
18. Wei G, Lonardo F, Ueda T, et al. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Int J Cancer 1999;80:199-204.
19. Park HR, Jung WW, Bertoni F, et al. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma. Pathol Res Pract 2004;200: 439-445.
20. Lopez-Guerrero JA, Lopez-Gines C, Pellin A, et al. Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma. Diagn Mol Pathol 2004;13:81-91.
21. Bertoni F, Bacchini P, Fabbri N, et al. Osteosarcoma. Low-grade intraosseous-type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma. Cancer 1993;71: 338-345.
22. Lin J, Yao L, Mirra JM, et al. Osteochondroma like parosteal osteosarcoma: a report of six cases of a new entity. AJR Am J Roentgenol 1998;170:1571-1577.
23. Dorfman HD, Ishida T, Tsuneyoshi M. Exophytic variant of fibrous dysplasia (fibrous dysplasia protuberans). Hum Pathol 1994;25:1234-1237.
24. Meneses MF, Unni KK, Swee RG. Bizarre parosteal osteochondromatous proliferation of bone (Noras lesion). Am J Surg Pathol 1993;17:691-697.
25. de Silva MV, Reid R. Myositis ossificans and fibroosseous pseudotumor of digits: a clinicopathological review of 64 cases with emphasis on diagnostic pitfalls. Int J Surg Pathol 2003;11:187-195.
26. Bahk WJ, Mirra JM. Pseudoanaplastic tumors of bone. Skeletal Radiol 2004;33:641-648.
27. Okada K, Nishida J, Morita T, et al. Low-grade intraosseous osteosarcoma in northern Japan: advantage of AgNOR and MIB-1 staining in differential diagnosis. Hum Pathol 2000;31:633-639.
28. Pollandt K, Engels C, Kaiser E, et al. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma. Virchows Arch 2001;439:170-175.
29. Lopes MA, Nikitakis NG, Ord RA, et al. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Oral Oncol 2001;37:566-571.
30. Ragazzini P, Gamberi G, Benassi MS, et al. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. Cancer Detect Prev 1999;23:129-136.
31. Unni KK, Dahlin DC. Grading of bone tumors. Semin Diagn Pathol 1984;1:165-172.
32. Dorfman HD, Weiss SW. Borderline osteoblastic tumors: problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol 1984;1:215-234.
33. Binh MB, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 2005;29:1340-1347.
34. Pilotti S, Della Torre G, Mezzelani A, et al. The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma. Br J Cancer 2000;82:1271-1275.
35. Mejia-Guerrero S, Quejada M, Gokgoz N, et al. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. Genes Chromosomes Cancer 2010;49:518-525.